Five-year recurrence/survival after pancreatoduodenectomy for pancreatic adenocarcinoma: does pre-existing diabetes matter? Results from the Recurrence After Whipple's (RAW) study.

Rajagopalan, Ashray; Aroori, Somaiah; Russell, Thomas B; Labib, Peter L; Ausania, Fabio; Pando, Elizabeth; Roberts, Keith J; Kausar, Ambareen; Mavroeidis, Vasileios K; Marangoni, Gabriele; Thomasset, Sarah C; Frampton, Adam E; Lykoudis, Pavlos; Maglione, Manuel; Alhaboob, Nassir; Bari, Hassaan; Smith, Andrew M; Spalding, Duncan; Srinivasan, Parthi; Davidson, Brian R; Bhogal, Ricky H; Dominguez, Ismael; Thakkar, Rohan; Gomez, Dhanny; Silva, Michael A; Lapolla, Pierfrancesco; Mingoli, Andrea; Porcu, Alberto; Shah, Nehal S; Hamady, Zaed Z R; Al-Sarrieh, Bilal; Serrablo, Alejandro; Croagh, Daniel

Name:

Publisher version

Affiliation

University Hospitals Coventry and Warwickshire NHS Trust; University Hospitals Birmingham NHS Foundation Trust

Publication date

2024-04-26

Subject

Endocrinology
Surgery
Gastroenterology

Metadata

Show full item record

Abstract

Diabetes mellitus (DM) has a complex relationship with pancreatic cancer. This study examines the impact of preoperative DM, both recent-onset and pre-existing, on long-term outcomes following pancreatoduodenectomy (PD) for pancreatic ductal adenocarcinoma (PDAC).

Citation

HPB (Oxford) . 2024 Aug;26(8):981-989

Type

Article

Five-year recurrence/survival after pancreatoduodenectomy for pancreatic adenocarcinoma: does pre-existing diabetes matter? Results from the Recurrence After Whipple's (RAW) study.

Author

Affiliation

Publication date

Subject

Metadata

Abstract

Citation

Type

Handle

DOI

PMID

Journal

Publisher

Scopus Count

Collections